Turn Therapeutics (NASDAQ:TTRX) Insider Abraham Chesed Buys 14,286 Shares of Stock

Turn Therapeutics Inc. (NASDAQ:TTRX) insider Abraham Chesed acquired 14,286 shares of the business’s stock in a transaction dated Thursday, October 23rd. The stock was purchased at an average price of $4.60 per share, with a total value of $65,715.60. Following the acquisition, the insider owned 1,447,268 shares of the company’s stock, valued at approximately $6,657,432.80. This trade represents a 1.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Turn Therapeutics Trading Down 0.2%

Shares of Turn Therapeutics stock opened at $5.24 on Friday. Turn Therapeutics Inc. has a fifty-two week low of $4.07 and a fifty-two week high of $26.50.

About Turn Therapeutics

We are a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Our patented mixing process — commercially referred to as PermaFusion™ (“PermaFusion”) — enables stable suspension of polar, water-soluble active pharmaceutical ingredients (“APIs”) in oil-based carriers without the use of emulsifiers.